5Y revenue growth near 52W lows
High momentum with strong forward PE range
High dividend yield with low debt-to-equity ratios
Large-cap stocks with stable beta for lower volatility
Undervalued stocks with reasonable forward PE and market cap
High-beta stocks with significant share price movement potential
Mid to large-cap stocks with strong growth potential in the stock market
Affordable stocks with consistent dividend payouts
Small-cap companies with low debt levels in the stock market
Low PE and low beta for conservative investors
Symbol | Name | Sector | Industry | Marketcap | Regularmarketprice | Debttoequity | Beta | Forwardpe | Dividendyield |
---|---|---|---|---|---|---|---|---|---|
ANTHEM | - | Healthcare | Biotechnology | 41137.93 Cr | 732.5 | 4.7 | - | - | - |
BALAXI | Balaxi Pharmaceuticals Limited | Healthcare | Biotechnology | 249.03 Cr | 48.92 | 9.64 | 0.59 | - | - |
BIOCON | Biocon Limited | Healthcare | Biotechnology | 51673.78 Cr | 387.2 | 66.26 | 0.22 | 39.03 | 0.14 |
BLUEJET | Blue Jet Healthcare Limited | Healthcare | Biotechnology | 15718.53 Cr | 906.15 | 1.76 | - | 55.46 | 0.1 |
CONCORDBIO | Concord Biotech Limited | Healthcare | Biotechnology | 19819.5 Cr | 1894.5 | 0.16 | - | 34.74 | 0.48 |
DCAL | Dishman Carbogen Amcis Limited | Healthcare | Biotechnology | 4122.62 Cr | 254.05 | 40.97 | 0.58 | 20.32 | - |
LYKALABS | Lyka Labs Limited | Healthcare | Biotechnology | 405.8 Cr | 113.7 | 37.9 | 0.49 | - | - |
ONESOURCE | ONESOURCE SPECL PHARMA L | Healthcare | Biotechnology | 22300.27 Cr | 1948.2 | 16.03 | - | 30.28 | - |
PANACEABIO | Panacea Biotec Limited | Healthcare | Biotechnology | 2558.75 Cr | 417.75 | 2.67 | 0.45 | - | - |
SMSLIFE | SMS Lifesciences India Limited | Healthcare | Biotechnology | 371.3 Cr | 1228.1 | 40.75 | 0.32 | - | 0.13 |
SUPRIYA | Supriya Lifescience Limited | Healthcare | Biotechnology | 5708.7 Cr | 693.9 | 0.54 | 0.2 | 23.05 | 0.11 |
ZOTA | Zota Health Care Limited | Healthcare | Biotechnology | 3333.24 Cr | 1197.9 | 65.72 | 0.37 | - | 0.08 |